Dr Lal Pathlabs is Business Standard Star SME of the Year 2016
December quarter could come under pressure, but growth set to improve from March quarter
The stock hit a new high of Rs 1,114, rallied 21% in past two trading sessions from Rs 922 on the BSE.
In its annual report, the company raised concerns of pricing control at the time of epidemics
The company had posted a revenue of Rs 791.3 crore for the fiscal year 2015-16
Total income from operations up 15% Rs 198 cr for the quarter; full-year profit up 38% at Rs 132 cr
The stock has soared 11% to Rs 947, its highest level since listing on the bourses in December last year